NanoSi CD36

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNanoSi CD36

Drug Alias NameNanoSi CD36

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionDNA synthesis inhibitors

TargetsNot applicable

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesQualiber Inc

China Registration ClassN/A

Active CompaniesQualiber Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A